Gonorrhea Diagnostic Market

Gonorrhea Diagnostic
Market GLOBAL INDUSTRY INSIGHTS, TRENDS,
OUTLOOK, AND OPPORTUNITY ANALYSIS,
2016-2025
© Coherent market Insights. All Rights Reserved
Ease of Testing: Can be done on non-invasive and self-collected specimens
Sexually transmitted Diseases (STDs) are one of the leading health problems globally, affecting the quality of life
and triggering serious morbidity and mortality. Gonorrhea is the most common among the various sexually
transmitted diseases with the age group of 15 to 24 years being the largest affected group. Around 350,062
gonorrhea cases were reported in the U.S. in 2014, with the national gonorrhea rate increasing to 110.7 cases
per 100,000 population. There are major complications when infected with sexually transmitted infections, which
have a detrimental effect on the reproductive system and can adversely affect health of the child conceived by an
infected mother. Infertility, cancers, and pregnancy complications are among the major complications that can
arise from the disease. Symptoms of gonorrhea in men include painful urination, swelling of testicles and pus
discharge. In women, symptoms encompass excessive vaginal discharge, painful urination, and abdominal pain.
Various complications such as ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis are most
common among females.
Thus, these complications further indirectly impact through facilitating sexual transmission of deadly virus such as
human immunodeficiency virus (HIV) and therefore, it also significantly adds to disease burden. In 2012,
approximately 357 million new cases of curable STIs (gonorrhea, chlamydia, syphilis and trichomoniasis) were
reported worldwide, which include 78 million cases of gonorrhea occurring at the age group of 15–49 year-olds.
More than a million Sexually Transmitted Infections are acquired every day of which around 50% infections turn
into Sexually Transmitted Diseases.
© Coherent market Insights. All Rights Reserved
Uncomplicated Gonorrhea: Developing Drugs for Treatment
Factors driving growth of the gonorrhea diagnostic market include increase in transmission of sexually transmitted infection. For
instance, according to Centers for Disease Control and Prevention data on STD Surveillance Report, in 2013, there were around 1.4
million reported cases of chlamydia, a rate of 456.1 cases per 100,000 population and in 2014, there were 350,062 reported cases of
gonorrhea (a rate of 110.7 per 100,000) in the U.S. Lack of biomedical products is a serious factor contributing to high incidence rate of
STDs in low income countries. For instance, estimates by the International Conference on Population and Development (2011), for SubSaharan Africa, indicates that only nine organizations donated condoms per year to people in the age group of 15–49-years and that
only one female condom per year is available for every 10 women of the same age range. Condom supplies in many high-burden
countries are still inadequate. Lower treatment cost for the test, where STI prevention counseling and HIV screenings are some of many
free preventive care benefits under the Affordable Care Act, though the tests themselves may cost you. In the U.S., private health
centers charge up to US$ 79 for individual STI tests and US$ 249 for comprehensive STI tests. The Florida Department of Health, for
instance, charges only $45 for its comprehensive STI test. However, lack of STI prevention counselling and dearth of trained laboratory
specialists are some of the factors restraining growth of the global gonorrhea diagnostics market.
Artificial intelligence and diagnostic imaging are in the testing phases and expected to dominate the gonorrhea diagnostic
market
The global gonorrhea diagnostic market is segmented on the basis of diagnostic type, end user, and geography. On the basis of
diagnostic type, the gonorrhea diagnostic market is divided into diagnostic imaging, molecular diagnostics, flow cytometry,
chromatography, gel micro droplets, liposomes, differential light scattering (DLS), artificial intelligence, and monoclonal antibodies test.
Molecular Diagnostic is sub-segmented into Nucleic Acid Amplification Tests (NAAT) and swab tests
Request Sample of Gonorrhea Diagnostic Market: https://www.coherentmarketinsights.com/insight/request-sample/126
© Coherent market Insights. All Rights Reserved
Gonorrhea diagnostic market traction is expected to be fueled by Growing Prevalence of STDs in Asia Pacific
Regional segmentation by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America,
Middle East, and Africa. North America accounts for the largest market share, mainly due to presence of major players
and adoption of advanced medical technologies in countries such as U.S. and Canada. In 2013, according to the U.S.
Center for Disease Control and Prevention (CDC) there were over 3.3 million cases of gonorrhea registered. Europe is
the second-largest gonorrhea diagnostic market, owing to the increasing prevalence of the disease in the region and
largely unmet needs in effective diagnosis and treatments. In 2013, according to European Centre for Disease
Prevention and Control, 52,995 gonorrhea cases were reported across 28 countries in the region; 61% of all cases
were reported in the U.K. Growing disposable income and increasing awareness levels among the populace in Asia
Pacific, along with a large population base is expected to drive the market in Asia Pacific in the near future.
Licensing approval: Approved for endocervical, vaginal, urethral, urine specimens
Key players operating the gonorrhea diagnostic market include Becton, Dickinson and Company, Baxter
International, Inc., Pfizer Inc., B. Braun Melsungen AG, Fresenius SE & CO. KGaA, Medtronic plc, Smiths Group plc,
Terumo Corporation, Moog, Inc., F. Hoffmann-la Roche Ltd., and Johnson & Johnson. Major companies in the market
are constantly working towards introducing innovative tests and lower the costs in order to improve patient outcomes
and enhance profitability.
Request the table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/126
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting
organization focused on assisting its plethora of clients achieve transformational
growth by helping them make critical business decisions. We are headquartered in
India, with an office at the global financial capital in the U.S. Our client base
includes players from across all business verticals in over 150 countries worldwide.
We are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods.
We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global
and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
© Coherent market Insights. All Rights Reserved
SYNDICATED RESEARCH
COUNTRY SPECIFIC
STUDIES
ABOUT COHERENT MARKET INSIGHTS
Industries we cater
SECTOR COVERAGE
Healthcare
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
Chemicals & Materials
Bulk Chemicals
Advanced Materials
Speciality and Fine
Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic
Ingredients
Polymers &
Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Gonorrhea Diagnostic Market Outlook, and Opportunity Analysis, 2016–2024